Onconetix, Inc. financial data

Symbol
ONCO on Nasdaq
Industry
Pharmaceutical Preparations
Location
201 E. Fifth Street, Suite 1900, Cincinnati, OH
State of incorporation
DE
Fiscal year end
December 31
Former names
Blue Water Biotech, Inc. (to 12/18/2023), Blue Water Vaccines Inc. (to 4/20/2023)
Latest financial report
10-Q - Q2 2024 - Aug 29, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 30.8 % -92%
Quick Ratio 3.04 %
Return On Equity -112 % -57.5%
Return On Assets -68.7 % -14.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 29.8M shares +65.6%
Common Stock, Shares, Outstanding 22.3M shares +36.1%
Entity Public Float 13M USD +32.7%
Common Stock, Value, Issued 228 USD +34.9%
Weighted Average Number of Shares Outstanding, Basic 22.2M shares +39.5%
Weighted Average Number of Shares Outstanding, Diluted 22.2M shares +39.5%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 700K USD
Revenue from Contract with Customer, Excluding Assessed Tax 705K USD
Cost of Revenue 604K USD
Research and Development Expense 916K USD -80.7%
General and Administrative Expense 8.8M USD +41.8%
Operating Income (Loss) -51.2M USD -208%
Nonoperating Income (Expense) -641K USD -197%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -14.3M USD -108%
Income Tax Expense (Benefit) 50.8K USD
Net Income (Loss) Attributable to Parent -14.3M USD -108%
Earnings Per Share, Basic -2.72 USD/shares -169%
Earnings Per Share, Diluted -2.72 USD/shares -169%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 25.8M USD +1235%
Accounts Receivable, after Allowance for Credit Loss, Current 171K USD
Inventory, Net 160K USD -86.3%
Assets, Current 2.04M USD -82.2%
Property, Plant and Equipment, Net 69.2K USD +390%
Operating Lease, Right-of-Use Asset 180K USD
Intangible Assets, Net (Excluding Goodwill) 20.3M USD +13.4%
Goodwill 36.5M USD
Assets 59.5M USD +99.9%
Accounts Payable, Current 3.17M USD +52.6%
Accrued Liabilities, Current 1.44M USD +1.34%
Liabilities, Current 20.6M USD +69.8%
Deferred Income Tax Liabilities, Net 2.81M USD
Operating Lease, Liability, Noncurrent 60.5K USD
Liabilities 24M USD +43.7%
Accumulated Other Comprehensive Income (Loss), Net of Tax -2.38M USD
Retained Earnings (Accumulated Deficit) -82.2M USD -183%
Stockholders' Equity Attributable to Parent -35.8M USD -374%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -28.7M USD -320%
Liabilities and Equity 59.5M USD +99.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -5.23M USD -18.6%
Net Cash Provided by (Used in) Financing Activities 5.21M USD
Net Cash Provided by (Used in) Investing Activities -4.58K USD +87.4%
Common Stock, Shares Authorized 250M shares 0%
Common Stock, Shares, Issued 22.8M shares +35%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -90.5K USD +98%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 931K USD -89.9%
Deferred Tax Assets, Valuation Allowance 15.7M USD +248%
Deferred Tax Assets, Gross 17M USD +277%
Depreciation 1.7K USD +30.6%
Payments to Acquire Property, Plant, and Equipment 4.58K USD +152%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -14.2M USD -107%
Operating Lease, Liability, Current 119K USD
Deferred Income Tax Expense (Benefit) -122K USD
Deferred Tax Assets, Operating Loss Carryforwards 10.2M USD +242%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 17K USD 0%
Additional Paid in Capital 49.4M USD +15.5%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 196K USD
Depreciation, Depletion and Amortization 207K USD +12073%
Deferred Tax Assets, Net of Valuation Allowance 1.3M USD +43275%
Share-based Payment Arrangement, Expense -775 USD -100%
Interest Expense 269K USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%